Nomura Micro Science (TSE:6254) Stock Faces Margin Squeeze After Softer Quarter

Nomura Micro Science stock enters this earnings season on a mixed footing. The shares closed at ¥4,225 on 7 August, with a solid 7 day gain but weaker 1 and 3 month performance. The market has been paying a rich P/E of about 45x for this semiconductor equipment specialist, while trailing net margin has eased to 6.8% from 10.1% a year earlier.

The headline from this Q1 2027 print is margin pressure. Quarterly net income of ¥239 million on revenue of ¥9,202 million leaves investors asking how much of the long term growth story still justifies that premium valuation.

Love the semiconductor exposure with Nomura Micro Science but concerned about rich valuations and creeping margin pressure? Check out our hand picked 56 resilient stocks with low risk scores as a benchmark for steadier balance sheets and earnings profiles.

Q1 2027 Earnings Summary

• Revenue (Q1 2027 vs. Q1 2026): ¥9,202 million vs. ¥12,403.144 million (lower year on year)
• Net Income (Q1 2027 vs. Q1 2026): ¥239 million vs. ¥464.401 million (lower year on year)
• Basic EPS (Q1 2027 vs. Q1 2026): ¥6.23 vs. ¥12.27 (lower year on year)
• Net Margin (Trailing 12 Months vs. Prior Year): 6.8% vs. 10.1% (compression in profitability)

Prefer clear visuals over scrolling through dense earnings tables and ratios? See Nomura Micro Science’s full financial picture, with a focus on its valuation and how the market is currently pricing the stock, in our company report for Nomura Micro Science.

Nomura Micro Science bullish story meets softer revenue

For investors who view Nomura Micro Science as a critical supplier to fabs and pharma plants, the latest quarter does not strongly support a growth-led story. Revenue of ¥9,202 million and basic EPS of ¥6.23 are both below the prior year. Net income of ¥239 million and a trailing net margin of 6.8% also indicate thinner profitability. The business still addresses essential end markets, but the recent direction of sales and earnings asks investors to place more weight on long-term industry importance than on current momentum.

Bearish concerns on cyclicality and margins get support

The cautious narrative around project and capex dependency finds support in this set of numbers. Revenue is lower than the ¥12,403.144 million booked in Q1 2026, and net income has declined from ¥464.401 million to ¥239 million. Net margin compression from 10.1% to 6.8% over the trailing 12 months highlights that profitability is under pressure. Recent share price returns also reflect this softer tone, with the stock down over 30 and 90 days even after a modest 7-day rebound.

Compare Nomura Micro Science’s softer revenue and slimmer margins with what institutional analysts are signaling. See the consensus price target analysis for Nomura Micro Science to check whether the street expects this premium P/E to hold or reset after the latest earnings.

Stay Ahead Of Your Next Move

If the rich P/E and recent margin pressure at Nomura Micro Science have your attention, register for free with Simply Wall St and add the stock to your Watchlist to track price against fair value and watch how the thesis develops. Once you decide to take a position, use the Portfolio Command Center to keep your holdings organised and receive focused alerts on the updates that matter most. For a broader lens on what other investors are thinking, join the Community and see which risks and opportunities others are debating in real time. By spotting potential catalysts and red flags early, you give yourself a better chance to stay ahead of the market rather than reacting after the fact.

Seeking Alternatives Beyond Nomura Micro Science?

Fresh ideas often catch their breakout phase before headlines. Use these under the radar for now stock lists while the momentum is still building and act now.

• Spot companies quietly building momentum before they start flying by scanning our curated list of 63 high quality undiscovered gems that many investors have not caught yet.
• Lock onto income opportunities that could steady a volatile portfolio by reviewing our hand picked group of 43 dividend fortresses before the yields drop and attention floods in.
• Get ahead of the next infrastructure breakout by scanning a focused collection of 36 power grid technology and infrastructure stocks that sit at the heart of long term electrification trends.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com